AstraZeneca, in a significant turn, has admitted for the first time in court documents that its Covid-19 vaccine may lead to a rare side effect.The Oxford–AstraZeneca Covid vaccine was sold globally under the brand names Covishield and Vaxzevria among others.
The pharmaceutical company faces a class-action lawsuit alleging serious injuries and deaths resulting from its vaccine, developed in collaboration with the University of Oxford.
